182 related articles for article (PubMed ID: 37080606)
1. Sublobar Resection versus Stereotactic Body Radiation Therapy for Clinical Stage I Non-Small Cell Lung Cancer: A Study Using Data from the Korean Nationwide Lung Cancer Registry.
Yun J; Cho JH; Hong TH; Yang K; Ahn YC; Kim HK; ;
Cancer Res Treat; 2023 Oct; 55(4):1171-1180. PubMed ID: 37080606
[TBL] [Abstract][Full Text] [Related]
2. Sublobar resection compared with stereotactic body radiation therapy and ablation for early stage non-small cell lung cancer: A National Cancer Database study.
Wu J; Bai HX; Chan L; Su C; Zhang PJ; Yang L; Zhang Z
J Thorac Cardiovasc Surg; 2020 Nov; 160(5):1350-1357.e11. PubMed ID: 32033815
[TBL] [Abstract][Full Text] [Related]
3. Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis.
Matsuo Y; Chen F; Hamaji M; Kawaguchi A; Ueki N; Nagata Y; Sonobe M; Morita S; Date H; Hiraoka M
Eur J Cancer; 2014 Nov; 50(17):2932-8. PubMed ID: 25281527
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC.
Ackerson BG; Tong BC; Hong JC; Gu L; Chino J; Trotter JW; D'Amico TA; Torok JA; Lafata K; Chang C; Kelsey CR
Lung Cancer; 2018 Nov; 125():185-191. PubMed ID: 30429018
[TBL] [Abstract][Full Text] [Related]
5. Propensity score-based analysis of stereotactic body radiotherapy, lobectomy and sublobar resection for stage I non-small cell lung cancer.
Kishi N; Matsuo Y; Menju T; Hamaji M; Nakakura A; Hanazawa H; Takehana K; Date H; Mizowaki T
J Radiat Res; 2022 Sep; 63(5):758-771. PubMed ID: 35818291
[TBL] [Abstract][Full Text] [Related]
6. A propensity-matched analysis of surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer in the elderly.
Wang P; Zhang D; Guo XG; Li XM; Du LH; Sun BJ; Fang XQ; Guo YH; Guo J; An L; Qu GP; Liu CT
Medicine (Baltimore); 2016 Dec; 95(52):e5723. PubMed ID: 28033277
[TBL] [Abstract][Full Text] [Related]
7. Matched-pair and propensity score comparisons of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgery.
Varlotto J; Fakiris A; Flickinger J; Medford-Davis L; Liss A; Shelkey J; Belani C; DeLuca J; Recht A; Maheshwari N; Barriger R; Yao N; DeCamp M
Cancer; 2013 Aug; 119(15):2683-91. PubMed ID: 23605504
[TBL] [Abstract][Full Text] [Related]
8. Survival Outcomes of Treatment with Radiofrequency Ablation, Stereotactic Body Radiotherapy, or Sublobar Resection for Patients with Clinical Stage I Non-Small-Cell Lung Cancer: A Single-Center Evaluation.
Iguchi T; Hiraki T; Matsui Y; Mitsuhashi T; Katayama N; Katsui K; Soh J; Sakurai J; Gobara H; Toyooka S; Kanazawa S
J Vasc Interv Radiol; 2020 Jul; 31(7):1044-1051. PubMed ID: 32471699
[TBL] [Abstract][Full Text] [Related]
9. Comparison Between Stereotactic Radiotherapy and Sublobar Resection for Non-Small Cell Lung Cancer.
Tamura M; Matsumoto I; Tanaka Y; Saito D; Yoshida S; Kakegawa S; Kumano T; Shimizu Y; Tamamura H; Takanaka T; Takemura H
Ann Thorac Surg; 2019 May; 107(5):1544-1550. PubMed ID: 30458155
[TBL] [Abstract][Full Text] [Related]
10. Is stereotactic ablative radiotherapy equivalent to sublobar resection in high-risk surgical patients with stage I non-small-cell lung cancer?
Mahmood S; Bilal H; Faivre-Finn C; Shah R
Interact Cardiovasc Thorac Surg; 2013 Nov; 17(5):845-53. PubMed ID: 23900381
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Treatment Outcomes Between Thoracoscopic Surgery and Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer.
Tian Q; Zhao X; Zhang C; Tian N; Bian H
Technol Cancer Res Treat; 2024; 23():15330338231219369. PubMed ID: 38378004
[No Abstract] [Full Text] [Related]
12. The role of surgery for stage I non-small cell lung cancer in octogenarians in the era of stereotactic body radiotherapy in the Netherlands.
de Ruiter JC; Heineman DJ; Daniels JM; van Diessen JN; Damhuis RA; Hartemink KJ
Lung Cancer; 2020 Jun; 144():64-70. PubMed ID: 32371262
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the outcomes of sublobar resection and stereotactic body radiotherapy for stage T1-2N0M0 non-small cell lung cancer with tumor size ≤ 5 cm: a propensity score matching analysis.
Dong B; Zhu X; Jin J; Chen Y; Ying H; Chen Y; Lu F; Shen W; Wang J; Chen M
J Thorac Dis; 2020 Oct; 12(10):5934-5954. PubMed ID: 33209426
[TBL] [Abstract][Full Text] [Related]
14. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
[TBL] [Abstract][Full Text] [Related]
15. A propensity-matched analysis of stereotactic body radiotherapy and sublobar resection for stage I non-small cell lung cancer in patients at high risk for lobectomy: the results in a Chinese population.
Yuan XS; Chen WC; Lin QR; Liu YJ; Zhu YY; Sun XJ; Wu QY; Liu JS; Xu YP
J Thorac Dis; 2021 Mar; 13(3):1822-1832. PubMed ID: 33841971
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis.
Scotti V; Bruni A; Francolini G; Perna M; Vasilyeva P; Loi M; Simontacchi G; Viggiano D; Lanfranchi B; Gonfiotti A; Topulli J; Olmetto E; Maragna V; Ferrari K; Bonti V; Comin C; Balduzzi S; D'Amico R; Lohr F; Voltolini L; Livi L
Clin Lung Cancer; 2019 Jan; 20(1):e53-e61. PubMed ID: 30348595
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of stereotactic body radiotherapy versus lobectomy for stage I non-small cell lung cancer: a propensity score matching analysis.
Lin Q; Sun X; Zhou N; Wang Z; Xu Y; Wang Y
BMC Pulm Med; 2019 May; 19(1):98. PubMed ID: 31118007
[TBL] [Abstract][Full Text] [Related]
18. Analysis of first recurrence and survival in patients with stage I non-small cell lung cancer treated with surgical resection or stereotactic radiation therapy.
Crabtree TD; Puri V; Robinson C; Bradley J; Broderick S; Patterson GA; Liu J; Musick JF; Bell JM; Yang M; Meyers BF
J Thorac Cardiovasc Surg; 2014 Apr; 147(4):1183-1191; discussion 1191-2. PubMed ID: 24507980
[TBL] [Abstract][Full Text] [Related]
19. Impact of stereotactic body radiation therapy volume on surgical patient selection, short-term survival, and long-term survival in early-stage non-small cell lung cancer.
Till BM; Mack S; Whitehorn G; Rahman U; Thosani D; Grenda T; Evans NR; Okusanya O
J Thorac Cardiovasc Surg; 2023 Feb; 165(2):471-479. PubMed ID: 36088141
[TBL] [Abstract][Full Text] [Related]
20. Lobectomy Versus Stereotactic Body Radiotherapy in Healthy Octogenarians With Stage I Lung Cancer.
Razi SS; Kodia K; Alnajar A; Block MI; Tarrazzi F; Nguyen D; Villamizar N
Ann Thorac Surg; 2021 May; 111(5):1659-1665. PubMed ID: 32891656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
